Pembrolizumab Granted 5 Additional Approvals in Japan – OncLive

January 10, 2019 by Health Topic Contributor

The Japan Pharmaceuticals and Medical Devices Agency has approved pembrolizumab for 5 new indications, including melanoma, advanced microsatellite …

>View original article
Author: